Fulltext

Expression of the chemokine receptor CCR6 in human renal inflammation

Welsh-Bacic, Desa ; Lindenmeyer, Maja ; Cohen, Clemens D. ; Draganovici, Dan ; Mandelbaum, Jana ; Edenhofer, Ilka ; Ziegler, Urs ; Regele, Heinz ; Wüthrich, Rudolf P. ; Segerer, Stephan

In: Nephrology Dialysis Transplantation, 2011, vol. 26, no. 4, p. 1211-1220

Add to personal list
    Title
    • Expression of the chemokine receptor CCR6 in human renal inflammation
    Author
    • Welsh-Bacic, Desa. Division of Nephrology, University Hospital, Zurich, Switzerland
    • Lindenmeyer, Maja. Division of Nephrology, University Hospital, Zurich, Switzerland
    • Cohen, Clemens D.. Division of Nephrology, University Hospital, Zurich, Switzerland
    • Draganovici, Dan. Medizinische Poliklinik-Innenstadt, University of Munich, Munich, Germany
    • Mandelbaum, Jana. Medizinische Poliklinik-Innenstadt, University of Munich, Munich, Germany
    • Edenhofer, Ilka. Department of Anatomy, University of Zurich, Switzerland
    • Ziegler, Urs. Center of Microscopy, University of Zurich, Zurich, Switzerland
    • Regele, Heinz. Clinical Institute of Pathology, University of Vienna, Vienna, Austria
    • Wüthrich, Rudolf P.. Division of Nephrology, University Hospital, Zurich, Switzerland
    • Segerer, Stephan. Division of Nephrology, University Hospital, Zurich, Switzerland
    Document Type
    • Postprint
    Language
    • English
    Published in
    • Nephrology Dialysis Transplantation, 2011, vol. 26, no. 4, p. 1211-1220. Oxford University Press
    Other Version
    OAI-PMH Identifier
    • oai:doc.rero.ch:293355
    Summary
    Background. Nodular inflammatory cell infiltrates with defined microarchitecture, i.e. tertiary lymphoid organs, develop in the tubulointerstitium during chronic renal inflammation. CCR6 and the corresponding ligand CCL20 are involved in the formation of gut-associated lymphatic tissue. We hypothesized that CCR6 might be involved in the formation of nodular infiltrates in the kidney. Methods. CCR6- and CD20-positive B cells were localized in renal biopsies with IgA nephropathy (n = 13), membranous nephropathy (n = 12), crescentic glomerulonephritis (cGN, n = 11) and chronic interstitial nephritis (n = 13), and in pre-implantation biopsies as controls (n = 8). The mRNA expression of CCR6 and the ligand CCL20 was quantified by real-time RT-PCR in 51 renal biopsies of the same disease entities. Results. In the pre-transplant biopsies, CCR6 was expressed by endothelial cells of peritubular and glomerular capillaries. In patients with glomerulonephritis, infiltrating cells were positive particularly in areas of nodular inflammatory cell accumulations. A major part of the CCR6-positive cells were CD20-positive B cells, but a part of the CD3-positive T cells were also found to be positive. The constitutive expression of CCR6 on the endothelium of glomerular capillaries was lost in biopsies with progressive injury. Tubular epithelial cells expressed CCR6 in inflamed kidneys, most commonly on the basolateral side. Conclusions. CCR6 and the corresponding ligand CCL20 might therefore be involved in the recruitment of T and B cells to organized nodular infiltrates in chronic renal inflammation. The functional role of endothelial CCR6 needs to be evaluated in further studies